Drug makers face bumpy road

Korea’s drug companies are facing a bumpy road ahead as a consequence of the government’s push to slash drug prices last April.

“The future growth of the domestic pharmaceutical industry is unclear because of dramatic changes in the business environment such as regulations by the government and intense competition among generic drugs,” said a market official.

Marketing activities have, in...